Back

Apelin-13 treatment enhances the stability of atherosclerotic plaques.

10 July 2016 (08:30 - 17:00)
Organised by: Logo
Congress Presentation Part of: Poster session 3 - Atherosclerosis Atherosclerosis Open Access Frontiers in CardioVascular Biology 2016 Council on Basic Cardiovascular Science

About the speaker

Photo
Doctor Rodrigo Fraga-Silva

12 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor S. Fiorelli (Milan, IT)
Abstract
Presentation thumbnail
Doctor P. Rinne (Turku, FI)
Abstract
Presentation thumbnail
Doctor D. Ozkaramanli Gur (Tekirdag, TR)
Abstract
Presentation thumbnail
Doctor T. Hofbauer (Vienna, AT)
Abstract

Access the full session

Session thumbnail
Poster session 3 - Atherosclerosis

The Event

Event poster

Frontiers in CardioVascular Biology 2016

10 July 2016 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Active-target liposomal drug shows significant atherosclerotic plaque regression effect: a proof-of-concept phase 1b/2a clinical trial
1 September 2025
thumbnail
Congress Presentation
Association of the exerkines apelin and irisin with myocardial fibrosis and cardiac dysfunction in early stages of hypertensive heart failure
22 May 2023
thumbnail
Congress Presentation
SMC-derived foam cells regulate atherosclerotic plaque stability via the crosstalk between ECM remodeling and WNT signaling
30 August 2025
thumbnail
Congress Presentation
Role of S100A4 in atherosclerosis development
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources